Takeda Pharmaceutical Co. (TAK)
(Delayed Data from NYSE)
$14.16 USD
+0.44 (3.21%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $14.16 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value C Growth C Momentum B VGM
Fundamental Charts
About Market Cap
As of the previous market close, Takeda Pharmaceutical Co. has a market cap of $43.66B, which represents its share price of $13.72 multiplied by its outstanding shares number of 3.18B. As a large-cap company, TAK's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
TAK 14.16 +0.44(3.21%)
Will TAK be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TAK based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TAK
KALV Stock Moves More Than 30% in a Week: What Is Driving This Rally?
Will Strong Asceniv Sales Drive ADMA Biologics Further?
TAK: What are Zacks experts saying now?
Zacks Private Portfolio Services
Ocular Therapeutix (OCUL) Moves 8.6% Higher: Will This Strength Last?
ADMA vs Takeda: Which Plasma Therapy Stock Is the Better Buy Today?
ADMA Looks to Expand Asceniv's Label: Will This Boost Sales?
Other News for TAK
Takeda Pharmaceutical Company Limited (TAK) Q1 FY2025 Earnings Call Transcript
TAK Crosses Below Key Moving Average Level
Takeda (TAK) Reaffirms FY25 Financial Projections
Takeda (TAK) Reports Decline in Q1 Revenue Amid Potential Pipeline Growth
Takeda reports Q1 core EPS 151 yen vs. 176 yen last year